Suppr超能文献

[来自动物的细菌的抗菌药敏试验:体外药敏试验方法及其对于生成治疗应用中最有用数据的适用性]

[Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications].

作者信息

Schwarz Stefan, Böttner Alexander, Hafez Hafez M, Kehrenberg Corinna, Kietzmann Manfred, Klarmann Dieter, Klein Günter, Krabisch Peter, Kühn Tilman, Luhofer Gabriele, Richter Angelika, Traeder Wolfgang, Waldmann Karl-Heinz, Wallmann Jürgen, Werckenthin Christiane

机构信息

Institut für Tierzucht, Bundesforschungsanstalt für Landwirtschaft (FAL), Neustadt-Mariensee.

出版信息

Berl Munch Tierarztl Wochenschr. 2003 Sep-Oct;116(9-10):353-61.

Abstract

In-vitro susceptibility testing provides valuable informations for choosing the most suitable antimicrobial agent for the control of bacterial infections in animals. Different diffusion and dilution methods, as conducted according to various approved performance standards, can be used to determine the in-vitro susceptibility of bacterial pathogens. In the present article, problems are discussed which arise from the use of different methods and the difficulty to interpret such results. While most approved performance standards were designed for testing of bacteria from human sources, the NCCLS document M31-A2 exclusively focusses on susceptibility testing of bacteria isolated from animals and--in contrast to all other standards--includes veterinary specific breakpoints for a number of antimicrobial agents used in veterinary medicine. Therefore, performance of in-vitro susceptibility testing of veterinary pathogens should follow the recommendations given in the NCCLS document M31-A2. The microdilution method is recommended as the method of choice for susceptibility testing. The result of a microdilution test is given as the minimum inhibitory concentration (MIC). This value provides a quantitative result which precisely indicates the degree of susceptibility of the tested bacterial strain and in return gives the veterinarian a clear guidance whether therapeutic intervention with the antibiotic in question will be successful.

摘要

体外药敏试验为选择最适合控制动物细菌感染的抗菌药物提供了有价值的信息。根据各种认可的性能标准进行的不同扩散和稀释方法,可用于确定细菌病原体的体外药敏情况。在本文中,讨论了因使用不同方法以及难以解读此类结果而产生的问题。虽然大多数认可的性能标准是为检测来自人类的细菌而设计的,但美国国家临床实验室标准委员会(NCCLS)文件M31 - A2专门关注从动物分离出的细菌的药敏试验,并且——与所有其他标准不同——包括了一些兽用抗菌药物的兽医专用折点。因此,兽医病原体的体外药敏试验应遵循NCCLS文件M31 - A2中的建议。微量稀释法被推荐为药敏试验的首选方法。微量稀释试验的结果以最低抑菌浓度(MIC)给出。该值提供了一个定量结果,精确地表明了受试细菌菌株的敏感程度,进而为兽医提供明确的指导,即使用所讨论的抗生素进行治疗干预是否会成功。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验